Market Cap 25.68M
Revenue (ttm) 69.26M
Net Income (ttm) -5.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.67%
Debt to Equity Ratio 0.25
Volume 223,500
Avg Vol 279,256
Day's Range N/A - N/A
Shares Out 39.47M
Stochastic %K 50%
Beta 1.58
Analysts Strong Sell
Price Target $3.00

Company Profile

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 248 960 9009
Fax: 248 960 9119
Address:
30142 South Wixom road, Wixom, United States
AHRMA
AHRMA Jun. 19 at 4:24 PM
$RMTI If we could just get a few forum members to stop posting childish cartoons and start posting objective, well thought out and researched commentary, I think this forum might begin to get more active.
0 · Reply
nyamsamb
nyamsamb Jun. 16 at 5:39 PM
$RMTI Increased 30%.
2 · Reply
AHRMA
AHRMA Jun. 16 at 4:10 PM
$RMTI A bit of commentary on stock manipulation and sheep following SPCX. The simple reality is that businesses typically are valued at between 3 and 5 times their annual gross profit. RMTI has no profit presently. So the current value of RMTI at .64 is based upon the hope of future profitability. For now, .64 is about right There is no manipulation going on. Any suggestion of manipulation is nothing more than someone trying to blame others for the poor investment they made in RMTI in the past. Regarding SPCx comments, that is someone failing to look objectively at opportunity. Those who invested in SPCx showed a terrific profit from their investment. The few folks on this forum who are crying about SPCx are simply angry that they missed a great opportunity. They could have sold their shares of RMTI and bought SPCx or AMD. All that said, I do think that at this point RMTI has some potential. That is why I sold SPCx that I had for a couple days and bought back 210,000 shares of RMTI.
1 · Reply
Mallingan
Mallingan Jun. 15 at 9:49 PM
$RMTI https://www.youtube.com/watch?v=8DJlogbrDcA&t=72s
0 · Reply
Mallingan
Mallingan Jun. 15 at 8:09 PM
$RMTI While Rockwell, which has an annual turnover of around 60 million, is valued at just 25 million at the market.
0 · Reply
Mallingan
Mallingan Jun. 15 at 7:55 PM
$RMTI """Peter Diamandis Dismisses SpaceX Valuation Concerns — 'You're Not Buying Just The Revenue... You're Buying Humanity's Future Economy' """ How much money will the poor idiots lose?
0 · Reply
Mallingan
Mallingan Jun. 14 at 9:22 PM
$RMTI$SPCX Valued at 2 TRILLIONNNNN and a few billion dollars in change. What is its revenue? 18 billion. It is valued at over 100 times its revenue... and it doesn't even generate a profit. It had a Q1 loss of over 4 billion.
2 · Reply
Mallingan
Mallingan Jun. 14 at 7:28 PM
$RMTI Do you think there will be at least another contract announcement or some interesting news before Q2? I don't think so, but I really hope I'm wrong. What do you think?
1 · Reply
AHRMA
AHRMA Jun. 13 at 3:54 PM
$RMTI As expected, the proposed reverse stock split has been approved. I see this as positive for RMTI shareholders. Those who watched or held shares through the previous RS were damaged. This upcoming RS is very different for a few key reasons. The previous RS began with over 100 million shares outstanding. A 1-11 ratio RS reduced that number to around 9 million shares. There are just under 40mm shares outstanding now. The ratio has yet to be determined but likely will be between 1-5 and 1-10. At the time of the previous RS, the company was losing 32 million dollars annually. Today the company is close to earnings neutral, with positive earnings likely in 2027 if not before. To summarize, the approval of the RS yesterday is a very good outcome for shareholders. Yes, your share count will be reduced, however the price per share will increase by the same ratio. So the value of your shares will remain the same. RMTI will continue to be listed on NASDAQ. All this is very good for shareholders
1 · Reply
Mallingan
Mallingan Jun. 13 at 3:49 PM
$RMTI Let's hope that Q2 will be at least slightly above market expectations and it is possible that we will save ourselves from RS
0 · Reply
Latest News on RMTI
Rockwell Medical Transcript: AGM 2026

Jun 12, 2026, 10:00 AM EDT - 7 days ago

Rockwell Medical Transcript: AGM 2026


Rockwell Medical Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 5 weeks ago

Rockwell Medical Proxy statement: Proxy filing


Rockwell Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Rockwell Medical Earnings Call Transcript: Q1 2026


Rockwell Medical Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Rockwell Medical Earnings release: Q1 2026


Rockwell Medical Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Rockwell Medical Quarterly report: Q1 2026


Rockwell Medical Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Rockwell Medical Slides: Q1 2026


Rockwell Medical Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

Rockwell Medical Proxy statement: Proxy filing


Rockwell Medical Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Rockwell Medical Proxy statement: Proxy filing


Rockwell Medical price target lowered to $4 from $5 at Maxim

2026-03-27T12:45:47.000Z - 3 months ago

Rockwell Medical price target lowered to $4 from $5 at Maxim

DVA


Rockwell Medical Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:00 AM EDT - 3 months ago

Rockwell Medical Earnings Call Transcript: Q4 2025


Rockwell Medical Annual report: Q4 2025

Mar 26, 2026, 8:00 AM EDT - 3 months ago

Rockwell Medical Annual report: Q4 2025


Rockwell Medical Earnings release: Q4 2025

Mar 26, 2026, 8:00 AM EDT - 3 months ago

Rockwell Medical Earnings release: Q4 2025


Rockwell Medical Slides: Investor presentation

Mar 26, 2026, 7:00 AM EDT - 3 months ago

Rockwell Medical Slides: Investor presentation


Rockwell Medical reports Q4 EPS 4c vs. 2c last year

2026-03-26T10:07:00.000Z - 3 months ago

Rockwell Medical reports Q4 EPS 4c vs. 2c last year


Rockwell Medical sees 2026 adjusted EBITDA $1M-$2M

2026-03-26T10:06:31.000Z - 3 months ago

Rockwell Medical sees 2026 adjusted EBITDA $1M-$2M


Rockwell Medical sees Q4 revenue $18.6M vs. $24.66M last year

2026-01-20T11:05:39.000Z - 5 months ago

Rockwell Medical sees Q4 revenue $18.6M vs. $24.66M last year


Rockwell Medical adds 30 new customers in the West

2026-01-12T11:15:55.000Z - 5 months ago

Rockwell Medical adds 30 new customers in the West


Rockwell Medical Adds 30 New Customers in the West

Jan 12, 2026, 6:00 AM EST - 5 months ago

Rockwell Medical Adds 30 New Customers in the West


Rockwell Medical Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Rockwell Medical Earnings Call Transcript: Q3 2025


Rockwell Medical Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Rockwell Medical Quarterly report: Q3 2025


Rockwell Medical Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Rockwell Medical Earnings release: Q3 2025


Rockwell Medical reports Q3 adjusted EPS 0c vs. 9c last year

2025-11-12T11:10:46.000Z - 7 months ago

Rockwell Medical reports Q3 adjusted EPS 0c vs. 9c last year


Rockwell Medical backs FY25 revenue view $65M-$70M

2025-11-12T11:10:34.000Z - 7 months ago

Rockwell Medical backs FY25 revenue view $65M-$70M


Rockwell Medical Announces Third Quarter 2025 Results

Nov 12, 2025, 6:00 AM EST - 7 months ago

Rockwell Medical Announces Third Quarter 2025 Results


Rockwell Medical to Exhibit at ASN Kidney Week 2025

Oct 28, 2025, 6:00 AM EDT - 8 months ago

Rockwell Medical to Exhibit at ASN Kidney Week 2025


Rockwell Medical Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Rockwell Medical Earnings Call Transcript: Q2 2025


Rockwell Medical Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Rockwell Medical Quarterly report: Q2 2025


Rockwell Medical Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Rockwell Medical Earnings release: Q2 2025


Rockwell Medical Announces Second Quarter 2025 Results

Aug 14, 2025, 6:00 AM EDT - 11 months ago

Rockwell Medical Announces Second Quarter 2025 Results


Rockwell Medical Earnings Call Transcript: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Earnings Call Transcript: Q1 2025


Rockwell Medical Quarterly report: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Quarterly report: Q1 2025


Rockwell Medical Earnings release: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Earnings release: Q1 2025


Rockwell Medical Announces First Quarter 2025 Results

May 12, 2025, 6:00 AM EDT - 1 year ago

Rockwell Medical Announces First Quarter 2025 Results


Rockwell Medical Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Proxy statement: Proxy Filing


Rockwell Medical Earnings Call Transcript: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Earnings Call Transcript: Q4 2024


Rockwell Medical Earnings release: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Earnings release: Q4 2024


Rockwell Medical Annual report: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Rockwell Medical Annual report: Q4 2024


Rockwell Medical Expands Distribution in the Philippines

Nov 19, 2024, 6:00 AM EST - 1 year ago

Rockwell Medical Expands Distribution in the Philippines


Rockwell Medical Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Rockwell Medical Earnings Call Transcript: Q3 2024


Rockwell Medical Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Rockwell Medical Quarterly report: Q3 2024


Rockwell Medical Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Rockwell Medical Earnings release: Q3 2024


Rockwell Medical Registration statement: Registration Filing

Oct 8, 2024, 8:00 AM EDT - 1 year ago

Rockwell Medical Registration statement: Registration Filing


Rockwell Medical Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings Call Transcript: Q2 2024


Rockwell Medical Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Quarterly report: Q2 2024


Rockwell Medical Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings release: Q2 2024


Rockwell Medical Promotes Tim Chole to Chief Commercial Officer

May 30, 2024, 6:00 AM EDT - 2 years ago

Rockwell Medical Promotes Tim Chole to Chief Commercial Officer


Rockwell Medical Earnings Call Transcript: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings Call Transcript: Q1 2024


Rockwell Medical Quarterly report: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Quarterly report: Q1 2024


Rockwell Medical Earnings release: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings release: Q1 2024


Rockwell Medical Proxy statement: Proxy Filing

Apr 15, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Proxy statement: Proxy Filing


Rockwell Medical Earnings Call Transcript: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings Call Transcript: Q4 2023


Rockwell Medical Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Annual report: Q4 2023


Rockwell Medical Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Rockwell Medical Earnings release: Q4 2023


AHRMA
AHRMA Jun. 19 at 4:24 PM
$RMTI If we could just get a few forum members to stop posting childish cartoons and start posting objective, well thought out and researched commentary, I think this forum might begin to get more active.
0 · Reply
nyamsamb
nyamsamb Jun. 16 at 5:39 PM
$RMTI Increased 30%.
2 · Reply
AHRMA
AHRMA Jun. 16 at 4:10 PM
$RMTI A bit of commentary on stock manipulation and sheep following SPCX. The simple reality is that businesses typically are valued at between 3 and 5 times their annual gross profit. RMTI has no profit presently. So the current value of RMTI at .64 is based upon the hope of future profitability. For now, .64 is about right There is no manipulation going on. Any suggestion of manipulation is nothing more than someone trying to blame others for the poor investment they made in RMTI in the past. Regarding SPCx comments, that is someone failing to look objectively at opportunity. Those who invested in SPCx showed a terrific profit from their investment. The few folks on this forum who are crying about SPCx are simply angry that they missed a great opportunity. They could have sold their shares of RMTI and bought SPCx or AMD. All that said, I do think that at this point RMTI has some potential. That is why I sold SPCx that I had for a couple days and bought back 210,000 shares of RMTI.
1 · Reply
Mallingan
Mallingan Jun. 15 at 9:49 PM
$RMTI https://www.youtube.com/watch?v=8DJlogbrDcA&t=72s
0 · Reply
Mallingan
Mallingan Jun. 15 at 8:09 PM
$RMTI While Rockwell, which has an annual turnover of around 60 million, is valued at just 25 million at the market.
0 · Reply
Mallingan
Mallingan Jun. 15 at 7:55 PM
$RMTI """Peter Diamandis Dismisses SpaceX Valuation Concerns — 'You're Not Buying Just The Revenue... You're Buying Humanity's Future Economy' """ How much money will the poor idiots lose?
0 · Reply
Mallingan
Mallingan Jun. 14 at 9:22 PM
$RMTI$SPCX Valued at 2 TRILLIONNNNN and a few billion dollars in change. What is its revenue? 18 billion. It is valued at over 100 times its revenue... and it doesn't even generate a profit. It had a Q1 loss of over 4 billion.
2 · Reply
Mallingan
Mallingan Jun. 14 at 7:28 PM
$RMTI Do you think there will be at least another contract announcement or some interesting news before Q2? I don't think so, but I really hope I'm wrong. What do you think?
1 · Reply
AHRMA
AHRMA Jun. 13 at 3:54 PM
$RMTI As expected, the proposed reverse stock split has been approved. I see this as positive for RMTI shareholders. Those who watched or held shares through the previous RS were damaged. This upcoming RS is very different for a few key reasons. The previous RS began with over 100 million shares outstanding. A 1-11 ratio RS reduced that number to around 9 million shares. There are just under 40mm shares outstanding now. The ratio has yet to be determined but likely will be between 1-5 and 1-10. At the time of the previous RS, the company was losing 32 million dollars annually. Today the company is close to earnings neutral, with positive earnings likely in 2027 if not before. To summarize, the approval of the RS yesterday is a very good outcome for shareholders. Yes, your share count will be reduced, however the price per share will increase by the same ratio. So the value of your shares will remain the same. RMTI will continue to be listed on NASDAQ. All this is very good for shareholders
1 · Reply
Mallingan
Mallingan Jun. 13 at 3:49 PM
$RMTI Let's hope that Q2 will be at least slightly above market expectations and it is possible that we will save ourselves from RS
0 · Reply
Mallingan
Mallingan Jun. 13 at 2:41 PM
$RMTI https://central.virtualshareholdermeeting.com/vsm/web?pvskey=RMTI2026
0 · Reply
Mallingan
Mallingan Jun. 12 at 8:55 PM
$RMTI @Uinvestwisely but what did the CEO say? Did you listen to the conference?
1 · Reply
Mallingan
Mallingan Jun. 12 at 2:10 PM
$RMTI Any shareholders who listened to the conference and can summarize it?
2 · Reply
AHRMA
AHRMA Jun. 12 at 1:15 PM
$RMTI One excellent bit of news. Mark Ravich (board memeber) will vacate his seat on the BoD as of today. Mark Ravich was on the BoD at Orchid Paper (TIS) during the time that once healthy company went bankrupt. Mark Ravich has been a board member since 2017. This entire time RMTI has lost value to the point of near bankruptcy. The first reverse split in May 2022 was part of his legacy. Mark Ravich has been a parasite for RMTI his entire time there. We can at least celebrate his leaving the company today!
1 · Reply
Eastwood63
Eastwood63 Jun. 12 at 7:24 AM
$RMTI Market Cap at ~$24.5M vs $70M+ expected 2026 revenue. Brutal chart but the business is actually improving. Gross margins ticking up (17%), automated lines saving $3M/year, and $23.9M in cash. This is a classic turnaround story, not a death spiral. Let the algos sell. 📈
2 · Reply
CLNG
CLNG Jun. 11 at 4:36 PM
$RMTI the idea to propose a R/S has tirned to be a very bad one; really hope they will not reach the minimum vote so they will pe forced to revert sp in order to avoid the delisting
7 · Reply
Mallingan
Mallingan Jun. 10 at 9:05 PM
$RMTI Only 2 days left until the vote, and then another 60 days for Q2, and we've been under a dollar for over 70 days now. Do they really want to keep us under a dollar for over 130 days? A company that's about to finish the year in profit, with revenues expected between 70 and 75 million? Let's see.
1 · Reply
Mallingan
Mallingan Jun. 9 at 10:37 PM
$RMTI We are twisting ourselves in knots out of fear, but honestly, in my opinion, they won't even do a reverse split here. It is highly likely that after Q2 we will already be back over a dollar and no longer thinking about the reverse split. And if that happens, it would provide an extra boost when, in Q3, everyone finally sees the company close in the green for the first time in its history.
0 · Reply
truthdotphd
truthdotphd Jun. 9 at 5:21 PM
$RMTI Here is how I made my decision: RS is not necessarily bad. Increased price reduces float and bigger institutions will be able to invest. Big institutions have minimum price requirements. Lots of new job postings for drivers and supply chain management (~15) on Linkedin over the past few months. New and renewed contracts. Highly undervalued: The market cap is close to the cash at hand. Also they don't seem to need to do more offerings. Strategic hiring of Joe Dawson from Nipro. Rashad post on Linkedin suggests they are a motivated team trying to win!
2 · Reply
AHRMA
AHRMA Jun. 9 at 4:50 PM
$RMTI Friday June 12 2026, shareholders will vote to authorize RMTI to execute another reverse split. This authoriziation does not mean that RMTI will absolutely execute another RS. It simply gives the company authorization to execute. Additionally, if shareholders to approve the authorization, there is currently no RS ratio established. It is reasonable to expect that this authorization will be approved. I believe it is also reasonable to expect that, once approved, RMTI will execute the RS and I belive that is in the best interest of the company and its shareholders. Would any of the few people still watching RMTI care to offer an estimate as to the RS ratio that shareholders can expect to see. My estimate of the RS ratio is 1-5. If so, this would bring PPS to around $3.50 (at least momentarily). The float would then be around 8 million shares at that point. As RMTI is not profitable, it is likely that after the RS, the company will dilute in order to fund any growth and acquisitions.
0 · Reply
Mallingan
Mallingan Jun. 6 at 7:22 PM
$RMTI Rashad wrote on his Links page: You have a choice…You can manage the gap or close it. I chose the latter. How do you interpret this? I interpret it as them finally solving all the logistics problems and maximizing transportation.
1 · Reply
Mallingan
Mallingan Jun. 6 at 1:54 AM
$RMTI In short, this CEO talked about over $100M by 2029, which means $40M more in just 3 years. Either he suddenly changed his personality—shifting from someone who always tries to be PRUDENT with expectations to a pipedream salesman, meaning a bastard playing games with shareholders—or, since he’s always been prudent, they’ve already made conservative estimates to reach that extra $40M in revenue over 3 years. In my opinion, 2026 will either be the springboard toward that $40M or the biggest bullshit ever.
1 · Reply